Immunity conferred by T-cells-based vaccine could last longer, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Upon being challenged with a lethal dose of SARS-CoV-2, the researchers found that 87.5 per cent of the mice vaccinated with the T-cell-based vaccine survived while only one of the control-group mice survived., Upon being challenged with a lethal dose of SARS-CoV-2, the researchers found that 87.5 per cent of the mice vaccinated with the T-cell-based vaccine survived while only one of the control-group mice survived., , Read More